Y. Hiraoka

发表

Intravenous IgG: supertherapy for myocarditis and acute dilated cardiomyopathy.

C. Kishimoto, H. Takada, Y. Hiraoka, 1999, Circulation.

Oral L-arginine prevents murine coxsackievirus B3 myocarditis.

H. Ochiai, C. Kishimoto, H. Takada, 2002, International journal of cardiology.

Oral Administration of l-Arginine Prevents Congestive Heart Failure in Murine Viral Myocarditis

H. Ochiai, C. Kishimoto, H. Takada, 2002, Journal of cardiovascular pharmacology.

Comparative effects of amlodipine monotherapy and combination therapy with betaxolol on cardiac autonomic nervous activity and health-related quality of life in patients with poorly controlled hypertension.

Y. Takeishi, M. Fujita, S. Senda, 2008, Circulation journal : official journal of the Japanese Circulation Society.

An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency mouse.

H. Ochiai, H. Kamiya, C. Kishimoto, 2003, Cardiovascular research.

[Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].

H. Ochiai, M. Kurokawa, C. Kishimoto, 2005, Journal of cardiology.

Effects of Immunoglobulin upon Murine Myocarditis Caused by Influenza A Virus: Superiority of Intact Type to F(ab′)2 Type

C. Kishimoto, H. Takada, Y. Hiraoka, 2004, Journal of cardiovascular pharmacology.

Protection against murine coxsackievirus B3 myocarditis by T cell vaccination.

M. Kitazawa, C. Kishimoto, H. Takada, 2000, Journal of molecular and cellular cardiology.

Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.

C. Kishimoto, H. Takada, Y. Hiraoka, 1995, Circulation.

[Transesophageal echocardiographic findings of cortical and perforating infarctions in patients with atrial fibrillation].

H. Inoue, T. Hirai, H. Asanoi, 1997, Journal of cardiology.

Extracellular matrix remodeling in coxsackievirus B3 myocarditis.

M. Kitazawa, C. Kishimoto, H. Takada, 1997, Clinical immunology and immunopathology.

Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction.

K. Miyamoto, Y. Hiraoka, T. Matsuda, 2011, JACC. Cardiovascular imaging.

The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.

S. Sasayama, H. Ochiai, M. Kurokawa, 1990, The Journal of pharmacology and experimental therapeutics.

Continuous administration of nicorandil decreases QT dispersion during the chronic phase of acute myocardial infarction.

Y. Hiraoka, N. Takahashi, I. Hamanaka, 2006, International heart journal.

Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice

H. Ochiai, M. Kurokawa, C. Kishimoto, 2007, Heart and Vessels.

Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.

M. Kurokawa, C. Kishimoto, H. Takada, 2003, Experimental and clinical cardiology.

Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditis

H. Ochiai, M. Kurokawa, C. Kishimoto, 2008, Heart and Vessels.

The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis

S. Sasayama, H. Ochiai, M. Kurokawa, 2005, Heart and Vessels.

Colony-stimulating factors and coxsackievirus B3 myocarditis in mice: Macrophage colony-stimulating factor suppresses acute myocarditis with increasing interferon-α

C. Kishimoto, H. Takada, Y. Hiraoka, 1995 .

Clinical and experimental studies in myocarditis.

C. Kishimoto, Y. Hiraoka, 1994, Current opinion in cardiology.

Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis.

S. Sasayama, M. Kurokawa, C. Kishimoto, 1997, The American journal of physiology.

T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice

C. Kishimoto, H. Takada, Y. Hiraoka, 2001, Basic Research in Cardiology.

Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.

S. Sasayama, H. Ochiai, M. Kurokawa, 1994, Circulation.

Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.

S. Sasayama, H. Ochiai, M. Kurokawa, 1993, Cardiovascular research.

Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.

S. Sasayama, H. Ochiai, M. Kurokawa, 1992, Cardiovascular research.

Effects of polyethylene glycol conjugated superoxide dismutase upon coxsackievirus B3 myocarditis in mice

S. Sasayama, C. Kishimoto, Y. Hiraoka, 1992 .

Late gadolinium-enhanced cardiovascular MRI at end-systole: feasibility study.

Atsushi Hayashi, Yuji Hiraoka, Hidenari Matsumoto, 2010, AJR. American journal of roentgenology.

Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.

H. Ochiai, M. Kurokawa, C. Kishimoto, 1996, Journal of the American College of Cardiology.

Anemia in Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, C. Izumi, 2019, Scientific Reports.

Title Anemia in Patients with Severe Aortic Stenosis

K. Yamaji, K. Kadota, Y. Furukawa, 2019 .

Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.

C. Kishimoto, H. Takada, Y. Hiraoka, 1995, European heart journal.

Anemia in Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, C. Izumi, 2019, Scientific Reports.

Diagnostic Utility of Quantifying Myocardial Flow Reserve with 99mTc-Sestamibi Dynamic SPECT Using a Standard Dual-Head SPECT Camera

Y. Hiraoka, K. Fukuyama, Y. Kitagawa, 2017 .

ECG-edited middiastolic phase reconstruction improves image quality at 64-MDCT coronary angiography of patients with atrial fibrillation.

T. Kondo, Satoshi Watanabe, Y. Hiraoka, 2008, AJR. American journal of roentgenology.